statistiche ricercatore

Continente	#
NA - Nord America	944
EU - Europa	698
AS - Asia	451
SA - Sud America	62
Continente sconosciuto - Info sul continente non disponibili	16
AF - Africa	13
OC - Oceania	2
Totale	2.186

Nazione	#
US - Stati Uniti d'America	922
RU - Federazione Russa	300
SG - Singapore	181
CN - Cina	137
GB - Regno Unito	113
VN - Vietnam	55
FI - Finlandia	53
SE - Svezia	53
BR - Brasile	51
IT - Italia	44
FR - Francia	32
DE - Germania	30
IE - Irlanda	25
HK - Hong Kong	24
CA - Canada	14
KR - Corea	12
BE - Belgio	9
UA - Ucraina	9
BD - Bangladesh	8
IN - India	8
TR - Turchia	8
AT - Austria	5
JP - Giappone	5
MX - Messico	4
NL - Olanda	4
PL - Polonia	4
ZA - Sudafrica	4
AR - Argentina	3
CH - Svizzera	3
EG - Egitto	3
ES - Italia	3
EU - Europa	3
AE - Emirati Arabi Uniti	2
AU - Australia	2
EC - Ecuador	2
HU - Ungheria	2
IL - Israele	2
IQ - Iraq	2
VE - Venezuela	2
AZ - Azerbaigian	1
BJ - Benin	1
BO - Bolivia	1
CL - Cile	1
CO - Colombia	1
CR - Costa Rica	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
ET - Etiopia	1
GR - Grecia	1
ID - Indonesia	1
JM - Giamaica	1
LA - Repubblica Popolare Democratica del Laos	1
LB - Libano	1
LT - Lituania	1
LV - Lettonia	1
MU - Mauritius	1
NO - Norvegia	1
PT - Portogallo	1
QA - Qatar	1
RO - Romania	1
RS - Serbia	1
SA - Arabia Saudita	1
SV - El Salvador	1
TG - Togo	1
TN - Tunisia	1
UY - Uruguay	1
UZ - Uzbekistan	1
Totale	2.173

Nome	#
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.	230
Prevalence of multiple sclerosis in Verona, Italy: an epidemiologic and genetic study	227
An active case of radiologically isolated syndrome: from MRI detection to multiple sclerosis	216
A panel of exploratory CSF biomarkers in patients with an initial demyelinating event of the CNS: does it add relevant information to usual work-up?	213
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review.	193
Cauda equina syndrome caused by lumbosacral epidural lipomatosis. A case report.	191
Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions	190
Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational study.	189
Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study.	185
Is platelet gel safe enough for neutropenic patients?	148
A Panel of Exploratory CSF Biomarkers in Patients with an Initial Demyelinating Event of the CNS: Does It Add Relevant Information to Usual Work-Up? (P02.080)	125
Real-Life Evaluation of the MOGAD Diagnostic Criteria: Application Challenges and Discrepancies	79
Totale	2.186

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	57	0	0	0	16	1	2	4	3	2	3	8	18
2022/2023	229	15	30	18	55	8	51	1	22	18	2	6	3
2023/2024	135	1	15	11	9	23	27	3	6	0	16	16	8
2024/2025	237	11	15	17	32	12	13	16	9	33	12	21	46
2025/2026	963	61	26	79	177	273	69	78	47	69	50	12	22
2026/2027	83	8	21	28	26	0	0	0	0	0	0	0	0
Totale													2.186

CATALOGO DEI PRODOTTI DELLA RICERCA